Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Aspirin versus vitamin K antagonist treatment guided by transoesophageal echocardiography in patients with atrial fibrillation: a pilot study.

Dinh T, Baur LH, Pisters R, Kamp O, Verheugt FW, Smeets JL, Cheriex EC, Lindeboom JE, Heesen WF, Tieleman RG, Prins MH, Crijns HJ; TIARA investigators.

Heart. 2014 Apr;100(7):563-8. doi: 10.1136/heartjnl-2013-305017. Epub 2014 Jan 31.

PMID:
24488608
2.
3.

[Incidence of complications of antithrombotic treatment in patients with atrial fibrillation].

Novaković Anucin S, Gnip S, Canak V, Radović P, Kovacev J, Mitić G.

Med Pregl. 2013 Nov-Dec;66(11-12):470-5. Croatian.

PMID:
24575635
4.

Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.

Chun KR, Bordignon S, Urban V, Perrotta L, Dugo D, Fürnkranz A, Nowak B, Schmidt B.

Heart Rhythm. 2013 Dec;10(12):1792-9. doi: 10.1016/j.hrthm.2013.08.025. Epub 2013 Aug 22.

PMID:
23973952
5.

Apixaban in patients with atrial fibrillation.

Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, Flaker G, Avezum A, Hohnloser SH, Diaz R, Talajic M, Zhu J, Pais P, Budaj A, Parkhomenko A, Jansky P, Commerford P, Tan RS, Sim KH, Lewis BS, Van Mieghem W, Lip GY, Kim JH, Lanas-Zanetti F, Gonzalez-Hermosillo A, Dans AL, Munawar M, O'Donnell M, Lawrence J, Lewis G, Afzal R, Yusuf S; AVERROES Steering Committee and Investigators.

N Engl J Med. 2011 Mar 3;364(9):806-17. doi: 10.1056/NEJMoa1007432. Epub 2011 Feb 10.

6.

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.

Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P.

Circulation. 2004 Oct 19;110(16):2287-92. Epub 2004 Oct 11.

7.

'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.

Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP.

Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28.

PMID:
24486284
8.

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.

Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2011 Jan-Feb;27(1):74-90. doi: 10.1016/j.cjca.2010.11.007.

PMID:
21329865
9.

Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients.

Lip GY, Lanitis T, Mardekian J, Kongnakorn T, Phatak H, Dorian P.

Stroke. 2015 Oct;46(10):2830-7. doi: 10.1161/STROKEAHA.115.009995. Epub 2015 Aug 27.

10.

Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy.

Lip GY, Skjøth F, Nielsen PB, Larsen TB.

Thromb Haemost. 2015 Oct;114(4):826-34. doi: 10.1160/TH15-07-0565. Epub 2015 Jul 30.

PMID:
26223245
11.

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.

Amadeus Investigators, Bousser MG, Bouthier J, Büller HR, Cohen AT, Crijns H, Davidson BL, Halperin J, Hankey G, Levy S, Pengo V, Prandoni P, Prins MH, Tomkowski W, Torp-Pedersen C, Wyse DG.

Lancet. 2008 Jan 26;371(9609):315-21. doi: 10.1016/S0140-6736(08)60168-3. Erratum in: Lancet. 2008 Dec 13;372(9655):2022.. Thorp-Pedersen, C [corrected to Torp-Pedersen, C].

PMID:
18294998
12.

Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation. An indirect comparison analysis.

Blann AD, Skjøth F, Rasmussen LH, Larsen TB, Lip GY.

Thromb Haemost. 2015 Aug;114(2):403-9. doi: 10.1160/TH15-05-0383. Epub 2015 Jun 11.

PMID:
26062437
14.

Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.

Goette A, Merino JL, Ezekowitz MD, Zamoryakhin D, Melino M, Jin J, Mercuri MF, Grosso MA, Fernandez V, Al-Saady N, Pelekh N, Merkely B, Zenin S, Kushnir M, Spinar J, Batushkin V, de Groot JR, Lip GY; ENSURE-AF investigators.

Lancet. 2016 Oct 22;388(10055):1995-2003. doi: 10.1016/S0140-6736(16)31474-X. Epub 2016 Aug 30. Erratum in: Lancet. 2016 Oct 22;388(10055):1984.

PMID:
27590218
15.

Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial.

Coppens M, Synhorst D, Eikelboom JW, Yusuf S, Shestakovska O, Connolly SJ.

Eur Heart J. 2014 Jul 21;35(28):1856-63. doi: 10.1093/eurheartj/ehu048. Epub 2014 Feb 25.

PMID:
24569032
16.

Vitamin K antagonist treatment in patients with atrial fibrillation and time in therapeutic range in four European countries.

Cotté FE, Benhaddi H, Duprat-Lomon I, Doble A, Marchant N, Letierce A, Huguet M.

Clin Ther. 2014 Sep 1;36(9):1160-8. doi: 10.1016/j.clinthera.2014.07.016. Epub 2014 Aug 21.

17.

Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II.

Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma C, Zint K, Elsaesser A, Bartels DB, Lip GY; GLORIA-AF Investigators.

Am J Med. 2015 Dec;128(12):1306-13.e1. doi: 10.1016/j.amjmed.2015.07.013. Epub 2015 Aug 1.

PMID:
26239094
18.

The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.

Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.

J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18.

19.

Stroke prevention in atrial fibrillation.

Freedman B, Potpara TS, Lip GY.

Lancet. 2016 Aug 20;388(10046):806-17. doi: 10.1016/S0140-6736(16)31257-0. Review.

PMID:
27560276
20.

Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial.

Diener HC, Eikelboom J, Connolly SJ, Joyner CD, Hart RG, Lip GY, O'Donnell M, Hohnloser SH, Hankey GJ, Shestakovska O, Yusuf S; AVERROES Steering Committee and Investigators.

Lancet Neurol. 2012 Mar;11(3):225-31. doi: 10.1016/S1474-4422(12)70017-0. Epub 2012 Feb 1.

PMID:
22305462

Supplemental Content

Support Center